Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
CTV.WS
CTV.WS was delisted on the 12th of February, 2025.
16 hedge funds and large institutions have $77.7K invested in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in 2024 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
51% more capital invested
Capital invested by funds: $51.6K → $77.7K (+$26.1K)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
6% less funds holding
Funds holding: 17 → 16 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$363 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$55 |
CTV.WS Hedge Fund Activity: Q1 2024 in Review
16 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) for Q1 2024, worth a combined $77.7K — up 51% from $51.6K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of CTV.WS and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Wolverine Asset Management, adding an estimated $363. The largest seller was BlackRock, cutting an estimated $55.
- 16 institutional investors held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) as of Q1 2024, down from 17 in Q4 2023.
- Funds reported $77.7K of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share stock for Q1 2024, up 51% quarter-over-quarter.
- 0 funds opened new Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share positions in Q1 2024 and 1 closed out, a net change of -1 holder.
- The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share buyer in Q1 2024 was Wolverine Asset Management, an estimated $363 added.
- The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share seller in Q1 2024 was BlackRock, an estimated $55 sold.
Based on aggregated 13F filings for Q1 2024.